Page 11 - Rna News Today

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 1,859 shares of the company’s stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $10.13, for a total transaction of $18,831.67. Following the transaction, the director now directly owns 17,471 shares of the company’s […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CFO Michael F. Maclean sold 1,616 shares of Avidity Biosciences stock in a transaction dated Monday, January 22nd. The shares were sold at an average price of $10.13, for a total value of $16,370.08. Following the completion of the transaction, the chief financial officer now directly owns […]

"U.S. Representatives introduce bipartisan resolution recognizing certified registered nurse anesthetists for their vital role in providing quality healthcare,

Moderna is expected to open an mRNA facility in Kenya to produce up to 500 million doses of vaccines every year.

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 1,859 shares of the firm’s stock in a transaction dated Monday, January 22nd. The stock was sold at an average price of $10.13, for a total transaction of $18,831.67. Following the sale, the director now directly owns 17,471 shares in the company, […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) insider W. Michael Flanagan sold 4,129 shares of the company’s stock in a transaction on Monday, January 22nd. The stock was sold at an average price of $10.13, for a total value of $41,826.77. Following the transaction, the insider now owns 35,871 shares in the company, valued […]

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 1,859 shares of the stock in a transaction that occurred on Monday, January 22nd. The stock was sold at an average price of $10.13, for a total value of $18,831.67. Following the transaction, the director now directly owns 17,471 shares of the […]

In 1982, the philosopher Karl Popper suggested that ‘science may be described as the art of systematic simplification’. In this mind-stretching book, Philip Ball seems to wish to prove Popper’s statement both wrong and correct. On the one hand, Ball is a clarifier supreme. It is hard to imagine a more concise, coherent, if also

Lyudmila A. Bazhenova, MD, discusses key factors in the management of unresectable non–small cell lung cancer, emphasizing the importance of understanding and performing biomarker testing in this population.

A member of Iran's Revolutionary Guards was shot dead in the country's southeastern province that borders Pakistan and Afghanistan., World News, Times Now